Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth R Rayburn

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
The Prostate|August 24, 2006
Experimental therapy of prostate cancer with an immunomodulatory oligonucleotide: effects on tumor growth, apoptosis, proliferation, and potentiation of chemotherapyElizabeth R Rayburn, Wei Wang, Zhuo Zhang, et al.
EMBO Reports|December 23, 2008
RYBP stabilizes p53 by modulating MDM2Deng Chen, Jianbing Zhang, Mao Li, et al.
Critical Reviews in Clinical Laboratory Sciences|May 20, 2016
FDA-approved drugs that interfere with laboratory tests: A systematic search of US drug labelsHui Yao, Elizabeth R Rayburn, Qiang Shi, et al.
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|August 5, 2005
Oncogenes as novel targets for cancer therapy (part II): Intermediate signaling moleculesZhuo Zhang, Mao Li, Elizabeth R Rayburn, et al.
Cancer Chemotherapy and Pharmacology|August 23, 2006
In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginsengWei Wang, Yuqing Zhao, Elizabeth R Rayburn, et al.
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|June 15, 2005
Oncogenes as novel targets for cancer therapy (part I): growth factors and protein tyrosine kinasesZhuo Zhang, Mao Li, Elizabeth R Rayburn, et al.
Molecular Cancer Therapeutics|July 5, 2006
Chemotherapy and chemosensitization of non-small cell lung cancer with a novel immunomodulatory oligonucleotide targeting Toll-like receptor 9Hui Wang, Elizabeth R Rayburn, Wei Wang, et al.
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|October 4, 2005
Oncogenes as novel targets for cancer therapy (part III): transcription factorsZhuo Zhang, Mao Li, Elizabeth R Rayburn, et al.
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|December 13, 2005
Oncogenes as novel targets for cancer therapy (part IV): regulators of the cell cycle and apoptosisZhuo Zhang, Mao Li, Elizabeth R Rayburn, et al.
Molecular Cancer Therapeutics|August 25, 2006
Immunomodulatory oligonucleotides as novel therapy for breast cancer: pharmacokinetics, in vitro and in vivo anticancer activity, and potentiation of antibody therapyHui Wang, Elizabeth R Rayburn, Wei Wang, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
The Prostate|August 24, 2006
Experimental therapy of prostate cancer with an immunomodulatory oligonucleotide: effects on tumor growth, apoptosis, proliferation, and potentiation of chemotherapyElizabeth R Rayburn, Wei Wang, Zhuo Zhang, et al.
EMBO Reports|December 23, 2008
RYBP stabilizes p53 by modulating MDM2Deng Chen, Jianbing Zhang, Mao Li, et al.
Critical Reviews in Clinical Laboratory Sciences|May 20, 2016
FDA-approved drugs that interfere with laboratory tests: A systematic search of US drug labelsHui Yao, Elizabeth R Rayburn, Qiang Shi, et al.
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|August 5, 2005
Oncogenes as novel targets for cancer therapy (part II): Intermediate signaling moleculesZhuo Zhang, Mao Li, Elizabeth R Rayburn, et al.
Cancer Chemotherapy and Pharmacology|August 23, 2006
In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginsengWei Wang, Yuqing Zhao, Elizabeth R Rayburn, et al.
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|June 15, 2005
Oncogenes as novel targets for cancer therapy (part I): growth factors and protein tyrosine kinasesZhuo Zhang, Mao Li, Elizabeth R Rayburn, et al.
Molecular Cancer Therapeutics|July 5, 2006
Chemotherapy and chemosensitization of non-small cell lung cancer with a novel immunomodulatory oligonucleotide targeting Toll-like receptor 9Hui Wang, Elizabeth R Rayburn, Wei Wang, et al.
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|October 4, 2005
Oncogenes as novel targets for cancer therapy (part III): transcription factorsZhuo Zhang, Mao Li, Elizabeth R Rayburn, et al.
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|December 13, 2005
Oncogenes as novel targets for cancer therapy (part IV): regulators of the cell cycle and apoptosisZhuo Zhang, Mao Li, Elizabeth R Rayburn, et al.
Molecular Cancer Therapeutics|August 25, 2006
Immunomodulatory oligonucleotides as novel therapy for breast cancer: pharmacokinetics, in vitro and in vivo anticancer activity, and potentiation of antibody therapyHui Wang, Elizabeth R Rayburn, Wei Wang, et al.
Pageof 4